Clinical Trial Update: Clinical Trial of HG146 Administered to Subjects with Advanced Solid Tumors or Lymphoma [Phase 1]

View source ↗

Summary

This entry reports a Phase 1 study of HG146 in subjects with advanced solid tumors or lymphoma. The sponsor is HitGen Inc., and the current trial status is unkn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lymphoma
• Solid Tumor

Drugs mentioned

• HG146

Snippet

Sponsor: HitGen Inc. | Conditions: Solid Tumor, Lymphoma | Phase 1 | Status: UNKNOWN